Literature DB >> 17997748

Evaluation of serum and urinary angiogenic factors in patients with endometriosis.

Si Hyun Cho1, Yoon Jin Oh, Anna Nam, Hye Yeon Kim, Joo Hyun Park, Jae Hoon Kim, Ki Hyun Park, Dong Je Cho, Byung Seok Lee.   

Abstract

PROBLEM: The aim of this study was to evaluate serum and urinary levels of vascular endothelial growth factors, tumor necrosis factor-alpha (TNF-alpha), and soluble fms-like tyrosine kinase (sFlt-1) in patients with endometriosis. METHOD OF STUDY: During surgery for pelvic pain, pelvic mass or infertility, serum and urine were collected. Of 70 patients, 46 had histology-proven endometriosis and 24 patients without endometriosis participated as controls.
RESULTS: Serum TNF-alpha levels and urinary sFlt-1 levels corrected for creatinine excretion were significantly increased in the endometriosis group (P=0.001 and P=0.011 respectively). Serum sFlt-1 levels and urinary sFlt-1 levels corrected for creatinine were significantly higher in patients with minimal-to-mild disease (P=0.014 and P=0.015 respectively), where serum TNF-alpha levels were increased in moderate-to-severe endometriosis (P<0.001).
CONCLUSION: The pathogenesis of minimal-to-mild endometriosis and moderate-to-severe endometriosis seems to be different. Increased sFlt-1 levels in serum and urine of minimal-to-mild disease indicate that sFlt-1 may have an important role in inhibiting angiogenic process of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997748     DOI: 10.1111/j.1600-0897.2007.00535.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  14 in total

Review 1.  Peripheral biomarkers of endometriosis: a systematic review.

Authors:  K E May; S A Conduit-Hulbert; J Villar; S Kirtley; S H Kennedy; C M Becker
Journal:  Hum Reprod Update       Date:  2010-05-12       Impact factor: 15.610

Review 2.  Challenges in uncovering non-invasive biomarkers of endometriosis.

Authors:  Quanah J Hudson; Alexandra Perricos; Rene Wenzl; Iveta Yotova
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-04

3.  Immune interactions in endometriosis.

Authors:  Jennifer L Herington; Kaylon L Bruner-Tran; John A Lucas; Kevin G Osteen
Journal:  Expert Rev Clin Immunol       Date:  2011-09       Impact factor: 4.473

Review 4.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

5.  Elevated vascular endothelia growth factor-A in the serum and peritoneal fluid of patients with endometriosis.

Authors:  Hongbo Wang; Nowiah Gorpudolo; Yanhui Li; Dilu Feng; Zehua Wang; Yuan Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

Review 6.  Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.

Authors:  S Haider; M Knöfler
Journal:  Placenta       Date:  2008-11-22       Impact factor: 3.481

Review 7.  Urinary biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Emily Liu; Vicki Nisenblat; Cindy Farquhar; Ian Fraser; Patrick M M Bossuyt; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2015-12-23

Review 8.  Combination of the non-invasive tests for the diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Lucy Prentice; Patrick M M Bossuyt; Cindy Farquhar; M Louise Hull; Neil Johnson
Journal:  Cochrane Database Syst Rev       Date:  2016-07-13

9.  Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis.

Authors:  Andrei M Malutan; Tudor Drugan; Nicolae Costin; Razvan Ciortea; Carmen Bucuri; Maria P Rada; Dan Mihu
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

Review 10.  Update on Biomarkers for the Detection of Endometriosis.

Authors:  Amelie Fassbender; Richard O Burney; Dorien F O; Thomas D'Hooghe; Linda Giudice
Journal:  Biomed Res Int       Date:  2015-07-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.